We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Myocardial Perfusion Study to Detect Coronary Microvascular Abnormality in Diabetic Patients With Nonfatal Myocardial Infarction (GEMyCE 1)

This study is currently recruiting participants.
Verified April 2016 by State University of New York - Upstate Medical University
Sponsor:
ClinicalTrials.gov Identifier:
NCT01749683
First Posted: December 17, 2012
Last Update Posted: April 19, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
State University of New York - Upstate Medical University
  Purpose
The goal of this study is to use MCE (myocardial contrast/perfusion echocardiography) to study and compare short/long term change of myocardial perfusion abnormality and cardiac outcome in diabetic patients after nonfatal MI (heart attack), who are treated with different glucose control agents.

Condition
Myocardial Infarction

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Myocardial Perfusion Study to Detect Coronary Microvascular Abnormality in Diabetic Patients With Nonfatal Myocardial Infarction

Resource links provided by NLM:


Further study details as provided by State University of New York - Upstate Medical University:

Primary Outcome Measures:
  • Perfusion abnormalities in nondiabetic and diabetic patients [ Time Frame: short term (3 month) and long term (12 month). ]

Secondary Outcome Measures:
  • The effect of different glycemic control strategies on the reduction of coronary injury in diabetic and non-diabetic subjects [ Time Frame: short term (3 month) and long term (12 month) ]

Estimated Enrollment: 100
Study Start Date: August 2011
Estimated Primary Completion Date: August 2017 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 71 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Diabetic and nondiabetic patients will be initially recruited and studied after acute nonfatal MI and revascularization with either PCI or CABG
Criteria

Inclusion Criteria:

  • Diabetic and nondiabetic patients will be initially recruited and studied after acute nonfatal MI and revascularization with either PCI or CABG

Exclusion Criteria:

  • Patients are excluded if they are older than 70 year old, require mechanical ventilation, are receiving intravenous pressors or hemodynamic support, or if the motion of segments associated with infarct-related artery can not be accurately determined.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01749683


Contacts
Contact: Kan Liu, MD 315-464-9574 liuk@upstate.edu
Contact: Mark Chilton, MS 315-464-9574 chiltonm@upstate.edu

Locations
United States, New York
SUNY Upstate Medical University Recruiting
Syracuse, New York, United States, 13210
Contact: Annie Pennella, MS    315-464-9574      
Principal Investigator: Kan Liu, MD         
Sponsors and Collaborators
State University of New York - Upstate Medical University
  More Information

Responsible Party: State University of New York - Upstate Medical University
ClinicalTrials.gov Identifier: NCT01749683     History of Changes
Other Study ID Numbers: GEMyCE1
First Submitted: December 12, 2012
First Posted: December 17, 2012
Last Update Posted: April 19, 2016
Last Verified: April 2016

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases